Skip to main content

Labor & Employment

  • Ahold USA announces succession plans for Giant/Martin's president

    CARLISLE, Pa. — Ahold USA on Monday named Nick Bertram, SVP merchandising at Ahold USA, to president Giant/Martin's in January 2018. Tom Lenkevich, who has been Giant/Martin's president since 2014, is retiring at the end of the year.

  • AmerisourceBergen changes operating model, leadership team

    VALLEY FORGE, Pa. — AmerisourceBergen on Monday shared its new organizational structure, which it said was aimed at aligning the company with its customers’ needs while accelerating growth and supporting its corporate strategy. As a result, its customer-facing offerings will be divided into two divisions — pharmaceutical distribution and strategic global sourcing and global commercialization services and animal health.

  • Coty’s Macchio set to retire after 25 years

    NEW YORK — The mind behind Sally Hansen Miracle Gel and various other Coty products is retiring. Coty on Wednesday announced the departure of chief scientific officer Ralph Macchio, who has been with the company for 25 years and is set to depart on June 30.

  • Supreme Court ruling offers some clarity on biosimilar ‘patent dance’

    WASHINGTON — In a decision that will have a big impact on the burgeoning biosimilars market, the Supreme Court on Monday overturned an appeals court decision which said Sandoz had to wait 180 days under federal law after receiving Food and Drug Administration approval to launch its biosimilar of Amgen’s Neupogen (filgrastim), Zarxio (filgrastim-sndz). The court did not rule out the possibility of state law allowing such an injunction, sending that question to a lower court.

  • Smith Drug names new VP finance

    SPARTANBURG, S.C. — Smith Drug has named a new divisional VP finance following the promotion of Kyle Waltz, who will become Smith Drug parent company J M Smith’s VP corporate controller. Lena Jouran will take over the role, supporting both Smith Drug and Burlington Drug.

  • Diplomat adds former OptumRx exec to board

    Jeff Park was OptumRx’s COO from July 2015 to July 2016 following the company’s merger with Catamaran, where Park had been EVP operations since March 2014.
  • Revlon adds CFO duties to COO role as Figuereo retires

    NEW YORK — Revlon is losing one of its executives who played a key role in its acquisition of Elizabeth Arden. The company on Tuesday announced the retirement of CFO Juan Figuereo, who joined the company in April 2016.

    Revlon said that with the Elizabeth Arden acquisition complete and the transition under way, COO Chris Peterson would assume direct responsibility for the CFO role, effective immediately, in addition to his role overseeing finance, supply chain and IT functions.

  • Perrigo CEO to retire

    DUBLIN — Perrigo is looking for a new CEO. The company announced Monday that it had launched a search ahead of current CEO John Hendrickson’s retirement.

    Hendrickson currently is planning on staying until his replacement is appointed, as well as up to 60 days after to ensure a smooth transition. Hendrickson plans to stand for election to the board of directors at Perrigo’s Annual General Meeting on July 20, and will step down once the new CEO is appointed, the company said.

X
This ad will auto-close in 10 seconds